Freshnews.com logo Freshnews.com 1 month ago

Idenix Pharmaceuticals Initiates Phase II Clinical Trial of IDX184 in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)

CAMBRIDGE, Mass. , Nov. 3 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. Full Article at Freshnews.com

Related Topics:

Related Articles

Related Quotes

There are no results for this module. Edi the module to change the search term used to query related quotes.

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using our SmartMedia Services platform, which can give you thousands of content-rich, advertiser-friendly pages (like this one) on any topic and with full editorial control. Learn More »

    Our Customers
  2. Our Products
    Daylife Select

    A point & click tool to create dynamic content portals. Learn More »

  3. Daylife API

    Unlimited smart, customizable content to suit any publisher. Learn More »

  4. Enterprise API

    Use the Daylife Platform to distribute content across your sites. Learn More »

  5. SmartContext

    Weave the web's best content into your own. Learn More »

Browse More Photos

Daylife is the web's largest archive of news photos

  1. LONDON, ENGLAND - MAY 18:  Sadie Frost poses for photographs before getting tested for Hepatitis B and Hepatitis C to promote getting tested ahead of World Hepatitis Day 2009 (19th May 2009) on the first ever 'Get Tested!' bus at Leicester Square on May 18, 2009 in London, England.
  2. In conjunction with National Hepatitis Awareness Month, Rolland C. Dickson, M.D. , director of liver transplantation research at the Mayo Clinic College of Medicine in Jacksonville, FL, speaks to health professionals and advocates to raise awareness about Hepatitis C.

Cast of Characters